Y. Wei et al. / Tetrahedron 67 (2011) 8552e8558
8557
39.9, 27.4, 25.6 ppm. HRMS (ESI, MþH) calcd for C26H28N3O
NMR (400 MHz, DMSO)
d
¼13.5 (s, 1H, OH), 8.78 (s, 1H, ArH), 7.97 (d,
398.2232, found 398.2227.
J¼8.4 Hz, 1H, ArH), 7.77 (s, 1H, ArH), 7.54 (s, 1H, ArH), 7.43 (t, J¼7.6,
14.8 Hz, 1H, ArH), 6.99 (d, J¼29.6 Hz, 2H, ArH), 6.60 (d, J¼38.8 Hz,
2H, ArH), 5.79e5.67 (m, 1H, CH2]CH), 5.05e4.86 (m, 2H, CH2]
CH), 4.63 (s, 1H, CH), 3.91 (s, 3H, OCH3), 3.85 (s, 2H, CH2), 3.49e3.30
(m, 3H, CH), 2.82 (s, 2H, CH2), 2.39 (s, 1H, CH), 1.61 (m, 3H, CH), 1.22
4.2.4. Synthesis of Schiff base ligand 2c. Ligand 2c was prepared in
the same way as 2b from (8R,9R)-9-amino(9-deoxy)-epicinchonine
with salicylaldehyde. The product was obtained as a yellow solid,
78% yield. ½a 2D5
ꢃ
þ65.5 (c 1.0, CH2Cl2). Mp 88e89 ꢁC. IR (KBr) nmax
:
(s, 2H, CH2), 0.76 (s, 1H, CH). 13C NMR (100 MHz, DMSO)
d
¼157.3,
3444, 2927, 2862, 1627, 1278 cmꢀ1
.
1H NMR (400 MHz, CDCl3)
155.7, 147.8, 143.8, 131.3, 129.3, 129.2, 127.9, 125.5, 121.4, 119.7, 118.3,
114.9, 101.6, 60.6, 55.5, 45.9, 40.0, 38.1, 26.6, 24.4 ppm. HRMS (ESI,
MþH) calcd for C27H32N3O2 430.2400, found 430.2377.
d
¼9.91 (s, 1H, OH), 8.79 (d, J¼4.4 Hz, 1H, ArH), 8.46 (d, J¼9.20 Hz,
1H, CH]N), 8.08 (d, J¼11.20 Hz, 1H, ArH), 7.70e7.42 (m, 7H, ArH),
7.01 (t, J¼10.80 Hz, 1H, ArH), 5.92 (s, 1H, CH2]CH), 5.45 (s, 1H, CH),
5.13e5.07 (m, 2H, CH2]CH), 3.55 (d, J¼9.60 Hz, 1H, CH), 3.00 (m,
4H, CH), 2.31 (s, 1H, CH), 1.65 (s, 1H, CH), 1.54 (s, 1H, CH), 1.41e1.35
(m, 2H, CH), 1.00e0.87 (m, 1H, CH). 13C NMR (100 MHz, MeOD)
4.2.8. Synthesis of Schiff base ligand 2g. Ligand 2g was prepared in
the samewayas 2b from(8S,9S)-9-amino(9-deoxy)-epiquininewith
1,2-benzenedialdehyde. The product was obtained as a yellow solid,
d
¼163.4, 151.0, 148.9, 137.9, 134.0, 133.9, 133.6, 133.4, 130.8, 130.2,
54% yield. ½a 2D5
ꢃ
ꢀ65.0 (c 1.0, CH2Cl2). Mp 176e178 ꢁC. IR (KBr) nmax
:
129.9, 129.7, 129.6, 129.2, 127.9, 122.9, 120.5, 118.6, 115.4, 54.5, 49.7,
47.2, 40.5, 29.0, 27.3 ppm. HRMS (ESI, MþH) calcd for C26H28N3O
3398.2232, found 398.2227.
3413, 2972, 2860,1622,1226 cmꢀ1.1H NMR (400 MHz, CDCl3)
d
¼8.74
(d, J¼4 Hz, 2H, ArH), 8.01 (d, J¼9.2 Hz, 4H, ArH), 7.54 (d, J¼1.2 Hz, 2H,
ArH), 7.38e7.33 (m, 6H, ArH), 7.12 (s, 2H, ArH), 5.90e5.59 (m, 2H,
CH2]CH), 5.05e4.91 (m, 4H, CH2]CH), 4.67 (d, J¼20 Hz, 2H, CH),
3.85 (s, 6H, OCH3), 3.15e3.10 (dd, J¼10.4, 4, 9.6 Hz, 2H, CH),
2.85e2.60 (m, 10H, CH), 1.83e1.26 (m, 10H, CH). 13C NMR (100 MHz,
4.2.5. Synthesis of Schiff base ligand 2d. Ligand 2d was prepared in
the same way as 2b from (8R,9R)-9-amino(9-deoxy)-epiquinidine
with salicylaldehyde. The product was obtained as a yellow solid,
CDCl3)
d
¼157.7, 147.6, 142.0, 141.4, 129.3, 126.6, 120.9, 118.5, 114.7,
81% yield. ½a 2D5
ꢃ
þ70.0 (c 1.0, CH2Cl2). Mp 165e166 ꢁC. IR (KBr) nmax
:
106.3, 101.2, 71.3, 56.7, 55.8, 43.2, 42.0, 27.8, 27.3, 21.5 ppm. HRMS
3425, 2983, 2958, 1622, 1255 cmꢀ1
.
1H NMR (400 MHz, CDCl3)
(ESI, MþH) calcd for C48H53N6O2 745.4230, found 745.4225.
d¼10.00 (s, 1H, OH), 8.70 (d, J¼5.60 Hz, 1H, ArH), 8.36 (s, 1H, CH]
N), 8.01 (d, J¼12.00 Hz, 1H, ArH), 7.92 (s, 1H, ArH), 7.83 (d,
J¼10.00 Hz, 1H, ArH), 7.77 (m, 2H, ArH), 7.55 (d, J¼5.2 Hz, 1H, ArH),
7.38 (m, 2H, ArH), 5.77e5.72 (m, 1H, CH2]CH), 5.50 (s, 1H, CH),
5.01e4.88 (m, 2H, CH2]CH), 4.01 (s, 3H, OCH3), 3.66 (t, J¼11.6 Hz,
1H, CH), 3.52 (s, 1H, CH), 3.27e3.21 (m, 1H, CH), 2.76 (d, J¼15.60 Hz,
2H, CH2), 2.26 (s, 1H, CH), 1.62 (d, J¼34.8 Hz, 2H, CH2), 1.45e1.40 (m,
1H, CH), 1.26 (s, 1H, CH), 0.97e0.90 (m, 1H, CH). 13C NMR (100 MHz,
4.2.9. Ligand 2h was prepared as following step. Ligand 2b (128 mg,
0.3 mmol) and NaHCO3 were dissolved in 10 mL acetone. Dimethyl
sulfate (34 mL, 0.36 mmol) dissolved in 2 mL acetone was added into
the above solution drop by drop at 0 ꢁC. Then the mixture was
stirred at room temperature for 6 h. After that, 1 M NaOH (5 mL)
was added and stirred vigorously for 10 min to destruct the rem-
nant dimethyl sulfate. The aqueous phase was washed with ethyl
acetate (3ꢂ20 mL). The combined organic layers were removed
under reduced pressure. The residue was purified by flash chro-
matography on silica gel (CH2Cl2/methanol/Et3N 50:1:1) to afford
MeOD)
d
¼162.1, 160.0, 148.4, 146.6, 145.4, 140.5, 134.9, 133.3, 132.1,
131.9, 130.1, 129.6, 124.0, 120.0, 118.6, 117.7, 116.0, 102.8, 62.9, 60.2,
50.3, 47.6, 39.8, 28.8, 26.6, 25.4 ppm. HRMS (ESI, MþH) calcd for
C27H30N3O2 428.2338, found 428.2333.
yellow solid (2 h, 55 mg, 41% yield). ½a D25
ꢀ35.5 (c 1.0, CH2Cl2). Mp
ꢃ
183e184 ꢁC. IR (KBr) nmax: 2970, 2937, 2793, 2761, 2681, 1450 cmꢀ1
.
4.2.6. Synthesis of Schiff base ligand 2e. Ligand 2e was prepared in
the same way as 2b from (8S,9S)-9-amino(9-deoxy)-epiquinine
with benzaldehyde. The product was obtained as a light brown oil,
1H NMR (400 MHz, CHCl3)
d
¼8.77 (s, 1H, ArH), 8.39 (s, 1H, ArH),
8.05 (d, J¼9.2 Hz, 1H, ArH), 7.74 (s, 1H, ArH), 7.58 (d, J¼2.0 Hz, 1H,
ArH), 7.47 (d, J¼4.0 Hz, 2H, ArH), 7.41 (d, J¼6.8 Hz, 2H, ArH), 7.22 (d,
J¼8.0 Hz, 1H, ArH), 6.91 (d, J¼8.0 Hz, 1H, ArH), 6.84 (m, 1H, CH2]
CH), 5.82e5.74 (m, 1H, CH2]CH), 5.03e4.99 (m, 1H, CH2]CH), 4.96
(s, 1H, CH), 4.01 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.40e3.36 (m, 1H,
CH), 3.02 (s, 1H, CH), 2.94 (s, 1H, CH), 2.09 (s, 2H, CH2), 1.97 (s, 1H,
CH), 1.68 (s, 1H, CH), 1.59e1.57 (m, 1H, CH), 0.97e0.95 (m, 1H, CH).
79% yield. ½a 2D5
ꢃ
ꢀ46.4 (c 1.0, CH2Cl2). IR (KBr) nmax: 2939, 2864, 1627,
1278 cmꢀ1. 1H NMR (400 MHz, CDCl3)
d
¼8.77 (d, J¼5.2, 1H, ArH),
8.38 (s, 1H, CH]N), 8.06 (d, J¼12.4 Hz, 1H, ArH), 7.58 (s, 1H, ArH),
7.47e7.40 (m, 2H, ArH), 7.22 (d, J¼6.4 Hz, 1H, ArH), 6.92 (d,
J¼10.8 Hz, 1H, ArH), 6.84 (t, J¼10.0 Hz, 1H, ArH), 5.79 (m, 1H, CH2]
CH), 5.03e5.48 (m, 3H, CH2]CH and CH), 4.01 (s, 3H, OCH3), 3.59
(d, J¼11.6 Hz, 1H, CH), 3.27e3.16 (m, 2H, CH2), 2.82e2.78 (m, 2H,
CH2), 2.28 (s, 1H, CH), 1.68 (s, 1H, CH), 1.59 (m, 2H, CH2), 1.43 (m, 1H,
13C NMR (100 MHz, DMSO)
d¼165.7, 160.2, 159.3, 118.7, 116.3, 114.2,
102.2, 64.9, 56.1, 56.0, 55.5, 27.5, 27.4, 25.3 ppm. Anal. Calcd for
C28H31N3O2: C, 76.16; H, 7.08; N, 9.52. Found: C, 76.11; H, 7.15; N,
9.47. LC-MS (ES, MþH) calcd for C28H32N3O2 442.24, found 442.24.
CH), 0.89e0.84 (m, 1H, CH). 13C NMR (100 MHz, MeOD)
d
¼169.7,
164.1, 148.3, 145.3, 142.7, 142.6, 137.4, 132.7, 132.1, 131.5, 129.7, 129.5,
128.0, 123.8, 123.3, 115.1, 104.3, 103.3, 65.2, 61.5, 56.9, 49.3, 41.5,
40.7, 29.0, 28.7, 26.7 ppm. HRMS (ESI, MþH) calcd for C27H30N3O
412.2389, found 412.2383.
4.2.10. Preparation of Cu(II)/2b catalyst. To a solution of Schiff base
ligand 2b (201 mg, 0.5 mmol) in EtOH (10 mL), Cu(OAc)2$H2O
(50 mg, 0.25 mmol) in water (1.5 mL) was added and the mixture
was stirred for 3 h under reflux. After cooling down to 0 ꢁC, the Cu/
Schiff base 2b complex was collected and dried under reduced
pressure to afford the dark green solid (152 mg). The complex can
be stored under air at room temperature.
4.2.7. Ligand 2f was prepared as following step. A solution of 2b
(202 mg, 0.47 mmol) and NaBH4 (114 mg, 2.8 mmol) in absolute
ethanol (15 mL) was refluxed with stirring for 24 h. The solution
was cooled to room temperature and H2O (10 mL) was added to
destroy excessive NaBH4. The mixture solution was extracted with
CH2Cl2 (3ꢂ30 mL). The combined extracts were washed with
a saturated NH4Cl solution (3ꢂ10 mL), water (3ꢂ10 mL) and the
organic layer was dried over anhydrous MgSO4. After filtered and
removed the solvent under reduced pressure, white solid product
was obtained and purified by recrystallization with methanol as
4.3. General procedure for the asymmetric Henry reaction
The metal/Schiff base catalyst (0.025 mmol) was dissolved in
solvent (1 mL). Then, the corresponding aldehyde (0.25 mmol) was
added. After stirring for 1 h at room temperature, the mixture was
cool down to ꢀ20 ꢁC (or to indicated temperature). Then nitro-
alkane (1.25 mmol) and the corresponding basic additive were
added. The stirring was continued for indicated time and after that
a fawn-colored solid 2f, 92% yield. ½a D25
þ36.0 (c 1.0, CH2Cl2). Mp
ꢃ
134e135 ꢁC. IR (KBr) nmax: 3261, 2939, 2864, 1622, 1240 cmꢀ1. 1H